Radium-223, an alpha emitter, but not strontium-89, a beta emitter, improves survival and decreases the risk of symptomatic skeletal events in patients with bone metastases from castration-resistant prostate cancer, a meta-analysis found.
The American College of Sports Medicine reconvened the ACSM Roundtable to update its guidelines for prescribing exercise for patients and survivors of cancers.
According to the investigators, nearly 25% of patients with CKD have MDD, and both conditions are independent risk factors for cardiovascular events.
Further follow-up needed to assess benefit of PSA screening in male BRCA1 mutation carriers.
For men with newly diagnosed metastatic castration-resistant prostate cancer, starting with abiraterone plus prednisone followed by enzalutamide upon PSA progression significantly prolongs time to second PSA progression compared with the opposite sequence, a study found.
Strong inverse association found for PTEN-null cancer but not for PTEN-intact cancers
Even though the EMBRACE study adds to the literature, according to authors the “best way” to screen men with germline DNA damage repair abnormalities “remains unclear.”
Plant-based diets might lower risk, animal-based diets containing dairy might raise risk for prostate cancer
Depression and anxiety about cancer recurrence are among the issues that face many men following treatment for prostate cancer.
Patients with low-risk disease more likely to receive nondefinitive therapy at MultiD clinic versus SEER.